FIELD: molecular biology, biotechnology, medicine. SUBSTANCE: invention proposes a derivative that has five successively located immunoglobulin ICAM-1 domains and a cytoplasmatic domain ICAM-1 or transmembrane domain ICAM-1. DNA encoding a derivative of ICAM-1 is obtained by recombinant procedure. Derivative of ICAM-1 can be used as a highly effective antiinflammatory agent. EFFECT: enhanced effectiveness of a derivative. 3 dwg, 1 tbl, 1 ex
Authors
Dates
1999-02-20—Published
1989-09-28—Filed